Peripheral support catheter
To lead complex lesion procedures
PRODUCT FEATURES
Support to cross all lesions
Able to go through tortuous arteries
Perfect visibility
The 4 radiopaque markers assess accurately:
Sirolimus eluting peripheral stent
PRODUCT FEATURES
Stent Design
Coating technology
TransferWise, the iVascular proprietary technology that provides a homogenous drug elution that translates into lower rates of restenosis and inflammation score.
Our fluoro-acrylate polymer provides an early endothelialization and creates a thromboresistant layer.
CLINICAL SUPPORT
Angiolite BTK has demonstrated its safety and efficacy in the following clinical trial:
Prospective, real-life trial in BTK lesions. 88% PP at 6 months.
PTA peripheral balloon
PRODUCT FEATURES
Oceanus 14 pro
Designed for the most complex and distal lesions
Oceanus 18
Designed for all types of lesions in distal and proximal arteries
Oceanus 35
Designed for the proximal
lesions
Best flexibility and trackability
The smallest balloons (<2.5mm) have flexible tungsten markers and the bigger ones (>2.5mm) have Pt/Ir markers to ensure a good visibility.
High pushability and trackability
Excellent pushability in the proximal part and flexibility at the distal part.
High pushability
Ultra small balloons
Diameter: 1.25mm.
Length: 10 and 15 mm.
Smallest profiles
To cross the most complex lesions.
Long catheter lengthsy
170 and 200cm catheter available.
BX covered stent
You deserve visibility
PRODUCT FEATURES
Unique visibility
Unique balloon-expandable (BX) stent with radiopaque markers to facilitate the implantation and the post-expansion.
Excellent navigability and conformability
iVascular proprietary encapsulation technology
Proprietary technology to encapsulate the stent into an inner and outer ePTFE layer.
Ensures a complete encapsulation avoiding delamination.
Paclitaxel eluting PTA balloon dilatation catheter
The DCB you need
PRODUCT FEATURES
Easy navigation
Small profiles
Short deflation times and wide size range (0.014”, 0.018” and 0.035” guidewire compatibilities)
Coating technology matters Not all DCBs are the same
Has an ultrathin coating thanks to the nanodrop technology used to coat the balloons.
Ensures a durable coating due to its multilayer technology, with minimum drug loss during navigation.
Ensures a uniform artery treatment
CLINICAL SUPPORT
Luminor has demonstrated its safety and efficacy in long term follow-up and in different indications:
Multicenter, randomized and controlled trial, Luminor vs POBA. 90.1% fTLR at 3.5 years
Prospective, multicenter trial, with Luminor and iVolution combined therapy in TASC C&D lesions. 89.4% fTLR at 2 years
Prospective, multicenter trial, with Luminor and Angiolite BTK as bailout stenting in BTK. 81.6% fTLR at 1 year
Other trials: BIBLIOS,LUMBRA,LUMIFOLLOW, SOL JAPAN, LUMINOR registry.
Self-expanding peripheral stent system
Bring precision to treat your patients
PRODUCT FEATURES
Optimum visibility
iVolution pro has 2 markers delimiting the stent and 1 tungsten marker in the retractable sheath, indicating the implantation level.
Controlled and easy deployment
User-friendly stent thanks to its triple sheath design and ergonomic small handle. The deployment speed is modulated through the handle’s wheel.
Flexible and resistant stent design
The stress is homogeneously distributed to avoid stent fracture. iVolution pro open cell design offers the highest flexibility.
CLINICAL SUPPORT
iVolution pro has demonstrated its safety and efficacy in the following clinical trials
Prospective, multicenter trial in femoropopliteal TASC A&B lesions. 88.0% fTLR at 1 year
Prospective, multicenter trial, with Luminor and iVolution combined therapy in TASC C&D lesions. 89.4% fTLR at 2 years
Peripheral stent system
The illiac solution
PRODUCT FEATURES
Outstading catheter
Crimped on an Oceanus 35, offering short deflation times and great pushability and trackability.
Great profiles
6F compatible for all diameters.
Unique stent design
Provides superior conformability to the vessel wall.
Advance manufacturing process to minimise the potential restenosis.
No random picking ensuring an automatized analysis of 100% stents. Assures the perfect surface finishing. Accurate dimensional analysis of the stent struts. 3D control, struts 100% checked.
